EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
about
Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.Nanoformulations for combination or cascade anticancer therapy.Co-delivery of Doxorubicin Encapsulated PLGA Nanoparticles and Bcl-xL shRNA Using Alkyl-Modified PEI into Breast Cancer Cells.PLGA-Based Nanoparticles in Cancer Treatment
P2860
EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
EGF-modified mPEG-PLGA-PLL nan ...... ment strategy for lung cancer.
@en
type
label
EGF-modified mPEG-PLGA-PLL nan ...... ment strategy for lung cancer.
@en
prefLabel
EGF-modified mPEG-PLGA-PLL nan ...... ment strategy for lung cancer.
@en
P2093
P2860
P1433
P1476
EGF-modified mPEG-PLGA-PLL nan ...... ment strategy for lung cancer.
@en
P2093
Baoshan Han
Liubing Qin
Xiangyu Zhang
Yiwei Fang
Yourong Duan
P2860
P304
P356
10.3109/10717544.2015.1126769
P407
P577
2016-01-07T00:00:00Z